Literature DB >> 16596639

Crystal structures of the complexes of a group IIA phospholipase A2 with two natural anti-inflammatory agents, anisic acid, and atropine reveal a similar mode of binding.

Nagendra Singh1, Talat Jabeen, Aritra Pal, Sujata Sharma, Markus Perbandt, Christian Betzel, Tej P Singh.   

Abstract

Secretory low molecular weight phospholipase A(2)s (PLA(2)s) are believed to be involved in the release of arachidonic acid, a precursor for the biosynthesis of pro-inflammatory eicosanoids. Therefore, the specific inhibitors of these enzymes may act as potent anti-inflammatory agents. Similarly, the compounds with known anti-inflammatory properties should act as specific inhibitors. Two plant compounds, (a) anisic acid (4-methoxy benzoic acid) and (b) atropine (8-methyl-8-azabicyclo oct-3-hydroxy-2-phenylpropanoate), have been used in various inflammatory disorders. Both compounds (a) and (b) have been found to inhibit PLA(2) activity having binding constants of 4.5 x 10(-5) M and 2.1 x 10(-8) M, respectively. A group IIA PLA(2) was isolated and purified from the venom of Daboia russelli pulchella (DRP) and its complexes were made with anisic acid and atropine. The crystal structures of the two complexes (i) and (ii) of PLA(2) with compounds (a) and (b) have been determined at 1.3 and 1.2 A resolutions, respectively. The high-quality observed electron densities for the two compounds allowed the accurate determinations of their atomic positions. The structures revealed that these compounds bound to the enzyme at the substrate - binding cleft and their positions were stabilized by networks of hydrogen bonds and hydrophobic interactions. The most characteristic interactions involving Asp 49 and His 48 were clearly observed in both complexes, although the residues that formed hydrophobic interactions with these compounds were not identical because their positions did not exactly superimpose in the large substrate-binding hydrophobic channel. Owing to a relatively small size, the structure of anisic acid did not alter upon binding to PLA(2), while that of atropine changed significantly when compared with its native crystal structure. The conformation of the protein also did not show notable changes upon the bindings of these ligands. The mode of binding of anisic acid to the present group II PLA(2) is almost identical to its binding with bovine pancreatic PLA(2) of group I. On the other hand, the binding of atropine to PLA(2) is similar to that of another plant alkaloid aristolochic acid. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596639     DOI: 10.1002/prot.20970

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  6 in total

1.  Interactions of selected indole derivatives with phospholipase A₂: in silico and in vitro analysis.

Authors:  Kalarickal Vijayan Dileep; Chandran Remya; Ignatius Tintu; Madathilkovilakathu Haridas; Chittalakkottu Sadasivan
Journal:  J Mol Model       Date:  2013-01-13       Impact factor: 1.810

2.  NMDA receptors and the L-arginine-nitric oxide-cyclic guanosine monophosphate pathway are implicated in the antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice.

Authors:  Andiara E Freitas; Morgana Moretti; Josiane Budni; Grasiela O Balen; Sinara C Fernandes; Patricia O Veronezi; Melina Heller; Gustavo A Micke; Moacir G Pizzolatti; Ana Lúcia S Rodrigues
Journal:  J Med Food       Date:  2013-11       Impact factor: 2.786

Review 3.  Diagnostic and Therapeutic Value of Aptamers in Envenomation Cases.

Authors:  Steven Ascoët; Michel De Waard
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

4.  Purification and preliminary crystallographic analysis of a new Lys49-PLA2 from B. Jararacussu.

Authors:  Marcelo L Dos Santos; Fábio H R Fagundes; Bruno R F Teixeira; Marcos H Toyama; Ricardo Aparicio
Journal:  Int J Mol Sci       Date:  2008-05-08       Impact factor: 6.208

5.  The mode of inhibitor binding to peptidyl-tRNA hydrolase: binding studies and structure determination of unbound and bound peptidyl-tRNA hydrolase from Acinetobacter baumannii.

Authors:  Sanket Kaushik; Nagendra Singh; Shavait Yamini; Avinash Singh; Mau Sinha; Ashish Arora; Punit Kaur; Sujata Sharma; Tej P Singh
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

Review 6.  Perspective on the Therapeutics of Anti-Snake Venom.

Authors:  Isabel Gómez-Betancur; Vedanjali Gogineni; Andrea Salazar-Ospina; Francisco León
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.